Literature DB >> 19435139

Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.

P P Sancheti1, P Karekar, V M Vyas, M Shah, Y V Pore.   

Abstract

Solid dispersions of the poorly water-soluble drug ezetimibe were prepared with a surfactant, Pluronic 188 in different ratios and characterized by FTIR, XRD, DSC and dissolution studies. The melting method was employed to prepare the solid dispersions whereas a physical mixture (1:3) was prepared by co-grinding the individual components in a mortar. Physical studies demonstrated a significant reduction in crystallinity with a possibility of presence of amorphous character of drug in the solid dispersions of ezetimibe. Among all binary systems studied, the 1:3 proportion of ezetimibe: Pluronic 188 showed fastest dissolution rate (DE90: 73.38% +/- 3.95) suggesting optimum ratio of the surfactant used.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435139

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Melting Point Depression of Poly(ethylene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) Triblock Polymers in Supercritical Carbon Dioxide in the Presence of Menthol as a Solid Co-Plasticiser.

Authors:  Vivek Trivedi; Adejumoke Lara Ajiboye; Nichola J Coleman; Ruchir Bhomia; Marion Bascougnano
Journal:  Polymers (Basel)       Date:  2022-07-11       Impact factor: 4.967

2.  Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.

Authors:  Rehmana Rashid; Dong Wuk Kim; Abid Mehmood Yousaf; Omer Mustapha; Jong Hyuck Park; Chul Soon Yong; Yu-Kyoung Oh; Yu Seok Youn; Jong Oh Kim; Han-Gon Choi
Journal:  Int J Nanomedicine       Date:  2015-09-30

3.  An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.

Authors:  Hong-Mei Yan; Zhen-Hai Zhang; Yan-Rong Jiang; Dong-Mei Ding; E Sun; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.